Literature DB >> 14621975

Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium.

Bashar M Al-Taani1, Bassam M Tashtoush.   

Abstract

The aim of this work is to design pH-dependent swellable and erodable-buffered matrices and to study the effect of the microenvironment pH on the release pattern of diclofenac sodium. Buffered matrix tablets containing diclofenac sodium, physically mixed with hydrophilic polymer (hydroxypropyl methylcellulose [HPMC]) and pH-dependent solubility polymer (Eudragit L100-55) were prepared with different microenvironment pHs. The release of diclofenac sodium from the buffer matrices was studied in phosphate buffer solutions of pH 5.9 and 7.4. The swelling and erosion matrices containing only HPMC and Eudragit L100-55 were studied in phosphate buffer solution of pH similar to the microenvironment pHs of the matrices. Drug release from matrices was found to be linear as a function of time. Amount of drug released was found to be higher in the medium of pH 7.4 than that of pH 5.9. The rate of drug release increased with the increase of the microenvironment pH of the matrices as determined from the slope. The pattern of drug release did not change with the change of microenvironment pH. The swelling and erosion occurred simultaneously from matrices made up of HPMC and Eudragit L100-55. Both extent of swelling and erosion increased with increase of the medium pH. It was concluded from this study that changing the pH within the matrix influenced the rate of release of the drug without affecting the release pattern.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14621975      PMCID: PMC2750636          DOI: 10.1208/pt040343

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  An investigation into the erosion behaviour of a high drug-load (85%) particulate system designed for an extended-release matrix tablet. Analysis of erosion kinetics in conjunction with variations in lubrication, porosity and compaction rate.

Authors:  T Dürig; G M Venkatesh; R Fassihi
Journal:  J Pharm Pharmacol       Date:  1999-10       Impact factor: 3.765

2.  pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods.

Authors:  A Avdeef; C M Berger; C Brownell
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

3.  A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.

Authors:  M Z Khan; H P Stedul; N Kurjaković
Journal:  Drug Dev Ind Pharm       Date:  2000-05       Impact factor: 3.225

4.  Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix.

Authors:  K A Mehta; M S Kislalioglu; W Phuapradit; A W Malick; N H Shah
Journal:  Int J Pharm       Date:  2001-02-01       Impact factor: 5.875

5.  In vitro and in vivo erosion of two different hydrophilic gel matrix tablets.

Authors:  B Abrahamsson; M Alpsten; B Bake; A Larsson; J Sjögren
Journal:  Eur J Pharm Biopharm       Date:  1998-07       Impact factor: 5.571

6.  Hydrophobic anionic gel beads for swelling-controlled drug delivery.

Authors:  C J Kim; P I Lee
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

7.  Polyoxyethylene-poly(methacrylic acid-co-methyl methacrylate) compounds for site-specific peroral delivery.

Authors:  V Carelli; G Di Colo; E Nannipieri; B Poli; M F Serafini
Journal:  Int J Pharm       Date:  2000-07-20       Impact factor: 5.875

8.  Improvement in site-specific intestinal absorption of furosemide by Eudragit L100-55.

Authors:  T Terao; K Matsuda; H Shouji
Journal:  J Pharm Pharmacol       Date:  2001-04       Impact factor: 3.765

9.  Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates.

Authors:  M S Kislalioglu; M A Khan; C Blount; R W Goettsch; S Bolton
Journal:  J Pharm Sci       Date:  1991-08       Impact factor: 3.534

10.  Zero-order release formulation of oxprenolol hydrochloride with swelling and erosion control.

Authors:  K P Devi; K V Rao; S Baveja; M Fathi; M Roth
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

View more
  13 in total

1.  Design and in vitro/in vivo evaluation of extended release matrix tablets of nateglinide.

Authors:  Pushkar R Sharma; Shaila A Lewis
Journal:  J Young Pharm       Date:  2013-12-11

2.  Design and evaluation of matrix base with sigmoidal release profile for colon-specific delivery using a combination of Eudragit and non-ionic cellulose ether polymers.

Authors:  Laila Fatima Ali Asghar; Sajeev Chandran
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

3.  Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.

Authors:  Meltem Cetin; Alptug Atila; Yucel Kadioglu
Journal:  AAPS PharmSciTech       Date:  2010-08-10       Impact factor: 3.246

4.  Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers.

Authors:  Atul Kuksal; Ashok K Tiwary; Narendra K Jain; Subheet Jain
Journal:  AAPS PharmSciTech       Date:  2006-01-03       Impact factor: 3.246

5.  Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit.

Authors:  M A Roni; G Kibria; R Jalil
Journal:  Indian J Pharm Sci       Date:  2009-05       Impact factor: 0.975

6.  Evaluation of Mimosa pudica seed mucilage as sustained-release excipient.

Authors:  Kuldeep Singh; Ashok Kumar; Naresh Langyan; Munish Ahuja
Journal:  AAPS PharmSciTech       Date:  2009-09-18       Impact factor: 3.246

7.  Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination.

Authors:  Yassin El-Said Hamza; Mona Hassan Aburahma
Journal:  AAPS PharmSciTech       Date:  2009-11-18       Impact factor: 3.246

8.  Sugar end-capped poly-D,L-lactides as excipients in oral sustained release tablets.

Authors:  Sirpa Vuorinen; Jyrki Heinämäki; Osmo Antikainen; Mohammed Lahcini; Timo Repo; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2009-05-09       Impact factor: 3.246

9.  Design and study of lamivudine oral controlled release tablets.

Authors:  Punna Rao Ravi; Sindhura Ganga; Ranendra Narayan Saha
Journal:  AAPS PharmSciTech       Date:  2007-12-07       Impact factor: 3.246

10.  Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers.

Authors:  Harekrishna Roy; Chandan K Brahma; Sisir Nandi; Kirti R Parida
Journal:  Int J Appl Basic Med Res       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.